hTERT is the catalytic subunit of the telomerase and is hence required for telomerase maintenance activity and cancer cell immortalization. Here, we show that acute hTERT depletion has no adverse ...
WASHINGTON, DC / ACCESSWIRE / April 3, 2024 / In a significant stride towards active immune therapy of cancer, a recently featured article in Experimental Biology and Medicine (Volume 249, Issue 1) ...
Gene-specific outcomes in patients with Lynch syndrome treated by immune checkpoint blockade for advanced cancer. Menopausal hormone therapy after a diagnosis of breast cancer in women with a BRCA ...
Phase I study of immunization with dendritic cells (DC) modified with recombinant fowlpox encoding carcinoembryonic antigen (CEA) and the triad of costimulatory molecules CD54, CD58, and CD80 ...
Inovio Pharmaceuticals, Inc. announced that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's ...
Human telomerase is a ribonucleoprotein enzyme that is usually absent or rare in normal somatic cells, but is highly expressed in cancer cells. This suggests that it plays an important role in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results